Buy Rioteph 1 mg (Riociguat) – Generic Adempas for Pulmonary Hypertension

Rioteph 1 mg is a generic form of riociguat, the active ingredient in Adempas, marketed by Cipla. It’s FDA-approved for treating pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in adults, including those who remain symptomatic after surgery.

How It Works

Riociguat stimulates soluble guanylate cyclase (sGC), increasing cyclic GMP levels. This relaxes pulmonary blood vessels, improves oxygen delivery, and reduces pressure in lung arteries—helping ease breathing and improve exercise capacity.

Indications & Benefits

• Treats WHO Group 1 PAH and inoperable or persistent/recurrent CTEPH (Group 4).
• Improves functional class and delays disease progression.
• Used alone or in combination with endothelin receptor antagonists or prostanoids. 

Dosage & Titration

• Typically starts at 1 mg three times daily. If hypotension is a concern or when taking strong CYP3A4/P-gp inhibitors, initial dose may be 0.5 mg TID. 
• Increase by 0.5 mg TID every two weeks to max 2.5 mg TID, based on blood pressure and tolerance. Monitor BP closely. 
• Smokers metabolize drug faster—adjust dosage accordingly. Reduce dose if smoking stops during therapy. 

Side Effects & Safety

• Common: headache, dizziness, indigestion, nausea, diarrhea, hypotension, edema. Most resolve over weeks.
• Serious: bleeding, severe anemia, syncope, pulmonary edema, pregnancy-related risks. Women must enroll in a REMS-like program.
• Contraindicated with nitrates, PDE‑5 inhibitors, pregnancy, and pulmonary hypertension due to interstitial lung disease (PH-IIP).

Precautions & Interactions

• Avoid combination with nitrates or nitric oxide donors and PDE‑5 inhibitors (e.g. sildenafil, tadalafil), as this may cause dangerous hypotension.
• Use caution if taking CYP3A4, P-gp or BCRP inhibitors; initiate at lower dose. 
• Ensure regular BP monitoring and dose adjustments per healthcare guidance.
• Not suitable for severe renal (Cl <15 mL/min) or Child‑Pugh Class C liver impairment.

Global Availability & Shipping

Prescription-only medication. Licensed generic available from Cipla (India). Discreet global shipping and delivery available via reputable international pharmacies. Patient support recommended, particularly for REMS enrollment.

📌 Frequently Asked Questions (FAQs)

1. What conditions does Rioteph 1 mg treat?

It treats pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in adults, particularly for those who cannot undergo surgery or remain symptomatic.

2. What is the dosing schedule?

Begin at 1 mg orally three times a day (or 0.5 mg TID if hypotension risk present). Increase slowly every two weeks to max 2.5 mg TID under BP monitoring. Adjust if you smoke. 

3. What side effects should be expected?

Common effects include headache, dizziness, nausea, low blood pressure, edema, and heartburn. Bleeding and anemia are less common but require medical attention. 

4. Can I take other medications with it?

It should not be used with nitrates or PDE‑5 inhibitors due to risk of severe hypotension. Inform your doctor about any CYP3A4 or P‑gp inhibitors you may be taking. 

5. Is Rioteph safe during pregnancy?

No—riociguat causes serious fetal harm. Women of childbearing potential must use reliable contraception and participate in a REMS-like program.